Osiris Therapeutics, Inc. Stock Option Award Agreement Terms and ConditionsStock Option Award Agreement • March 15th, 2019 • Osiris Therapeutics, Inc. • Biological products, (no disgnostic substances) • Maryland
This Stock Option Award Agreement, along with the Osiris Therapeutics, Inc. Stock Option Award Summary delivered herewith (the “Award Summary”), once signed by the individual named on the Award Summary (the “Participant”), shall constitute an Agreement made as of the Grant Date (as indicated on the Award Summary), by and between Osiris Therapeutics, Inc., a Maryland corporation having its principal office at 7015 Albert Einstein Drive, Columbia, MD 20146 (“Osiris” or the “Company”), and the Participant.
